| Product Code: ETC9975811 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Sarcopenia Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Sarcopenia Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Sarcopenia Market - Industry Life Cycle |
3.4 United States (US) Sarcopenia Market - Porter's Five Forces |
3.5 United States (US) Sarcopenia Market Revenues & Volume Share, By Supplement Type, 2021 & 2031F |
3.6 United States (US) Sarcopenia Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United States (US) Sarcopenia Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing aging population in the United States |
4.2.2 Growing awareness about the impact of sarcopenia on overall health |
4.2.3 Rising adoption of preventive healthcare measures |
4.2.4 Technological advancements in diagnostic tools for sarcopenia |
4.3 Market Restraints |
4.3.1 Limited availability of specific treatment options for sarcopenia |
4.3.2 Lack of standardized diagnostic criteria for sarcopenia |
4.3.3 High cost associated with diagnostic tests and treatment for sarcopenia |
4.3.4 Limited reimbursement policies for sarcopenia-related care |
5 United States (US) Sarcopenia Market Trends |
6 United States (US) Sarcopenia Market, By Types |
6.1 United States (US) Sarcopenia Market, By Supplement Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Sarcopenia Market Revenues & Volume, By Supplement Type, 2021- 2031F |
6.1.3 United States (US) Sarcopenia Market Revenues & Volume, By Protein Supplement, 2021- 2031F |
6.1.4 United States (US) Sarcopenia Market Revenues & Volume, By Vitamin D & Calcium Supplement, 2021- 2031F |
6.1.5 United States (US) Sarcopenia Market Revenues & Volume, By Vitamin B12 Supplement, 2021- 2031F |
6.2 United States (US) Sarcopenia Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Sarcopenia Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.2.3 United States (US) Sarcopenia Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.2.4 United States (US) Sarcopenia Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.2.5 United States (US) Sarcopenia Market Revenues & Volume, By Hypermarket & Supermarket, 2021- 2031F |
7 United States (US) Sarcopenia Market Import-Export Trade Statistics |
7.1 United States (US) Sarcopenia Market Export to Major Countries |
7.2 United States (US) Sarcopenia Market Imports from Major Countries |
8 United States (US) Sarcopenia Market Key Performance Indicators |
8.1 Average time to diagnose sarcopenia in the US population |
8.2 Percentage increase in research funding for sarcopenia-related studies |
8.3 Adoption rate of new diagnostic tools for sarcopenia |
8.4 Number of educational campaigns on sarcopenia awareness |
8.5 Percentage of healthcare providers trained in sarcopenia management and treatment |
9 United States (US) Sarcopenia Market - Opportunity Assessment |
9.1 United States (US) Sarcopenia Market Opportunity Assessment, By Supplement Type, 2021 & 2031F |
9.2 United States (US) Sarcopenia Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United States (US) Sarcopenia Market - Competitive Landscape |
10.1 United States (US) Sarcopenia Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Sarcopenia Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here